Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential
Frontiers in Cardiovascular Medicine · 16.07.2026 · 13
DOI: 10.3389/fcvm.2026.1883442 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 16.07.2026. Verfasst von Hang Zhan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Heart Center, Children's Hospital Zhejiang University School of Medicine, Zhejiang Key Laboratory of Neonatal Diseases, National Clinical Research Ce…. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocardial ischemia-reperfusion injury (MIRI) remains a major unresolved problem in cardiovascular medicine. It commonly occurs in coronary heart disease (CHD) patients following reperfusion therapy or cardiopulmonary bypass (CPB)–assisted cardiac surgery. Despite the clinical necessity of restoring blood flow, reperfusion itself paradoxically exacerbates myocardial injury. The resulting therapeutic dilemma underscores the need for innovative cardioprotective strategies. Recent studies suggest that protein lactylation (Kla), a newly identified post-translational modification (PTM) derived from lactate metabolism, plays a crucial role in cardiomyocytes by regulating metabolic adaptation, injury repair, stress responses, cell death, and cardiac remodeling. However, there is still no comprehensive synthesis of the role of Kla in MIRI. In this review, we critically examine the emerging evidence linking Kla to the pathogenesis of MIRI and further discuss potential therapeutic strategies targeting this epigenetic mechanism to alleviate reperfusion-induced myocardial injury.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Center, Children's Hospital Zhejiang University School of Medicine, Zhejiang Key Laboratory of Neonatal Diseases, National Clinical Research Center for Children and Adolescents' Health and Diseases, Hangzhou, Chin…
- Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Zitieren
APA
Zhan, H., Li, D., He, J., Hu, Y., Jiang, W., Zhang, J., Chen, W., & Xu, W. (2026). Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1883442
Vancouver
Zhan H, Li D, He J, Hu Y, Jiang W, Zhang J, et al. Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1883442
BibTeX
@article{Zhan2026,
author = {Zhan, Hang and Li, Die and He, Jiayao and Hu, Yuzhuang and Jiang, Wei and Zhang, Jiayu and Chen, Wei and Xu, Weize},
title = {Protein lactylation in myocardial ischemia-reperfusion injury: mechanisms and therapeutic potential},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1883442}
}
EUVIMED